HELIOS Kliniken

Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary intervention (2025) Jakob P, Varbella F, Linke A, Schwarz B, Felix SB, Seiffert M, Kesterke R, et al. Journal article Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial (2025) Stelljes M, Middeke JM, Bug G, Wagner-Drouet EM, Müller LP, Schmid C, Krause S, et al. Journal article Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma. (2025) Tomsitz D, Livingstone E, Loquai C, Kaatz M, Leiter U, Schilling B, Terheyden P, et al. Journal article A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in Germany (2025) Berthele A, Gödel C, Kallmann BA, Kowarik M, Lehmann-Horn K, Marziniak M, Rauer S, et al. Journal article DEGRO statement on the FAST-Forward trial: 10-year data of ultrahypofractionated radiation therapy for breast cancer (2025) Matuschek C, Borm K, Hörner-Rieber J, Dellas K, Duma NM, Dunst J, Fietkau R, et al. Journal article Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study (2024) Neven P, Stahl N, Vidal M, Martín M, Kaufman PA, Harbeck N, Hunt KK, et al. Journal article Revision of the "guideline of the German Medical Association on Quality Assurance in Medical Laboratory Examinations - Rili-BAEK" (2024) Ahmad-Nejad P, Bauersfeld W, Baum H, Behre HM, Burkhardt R, Cassens U, Ceglarek U, et al. Journal article Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations” [Eur J Cancer 207 (2024) 114158](S0959804924008141)(10.1016/j.ejca.2024.114158) (2024) Kron A, Scheffler M, Wiesweg M, Hummel HD, Kulhavy J, Gatteloehner S, Kollmeier J, et al. Journal article, Erratum The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype (2024) Ziegler P, Hartkopf AD, Wallwiener M, Häberle L, Kolberg HC, Hadji P, Tesch H, et al. Journal article